Silver Oak Securities’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
20,680
+4,091
+25% +$224K 0.08% 231
2026
Q1
$868K Buy
16,589
+3,254
+24% +$166K 0.06% 293
2025
Q4
$677K Buy
+13,335
New +$617K 0.05% 377

Other funds holding SBIO

Silver Oak Securities's SBIO Position: Q2 2026 in Review

Silver Oak Securities increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 25% in Q2 2026, buying an estimated $224K and bringing the position to 20,680 shares worth $1.34M. The position accounts for 0.08% of the portfolio, ranked #231.

Silver Oak Securities first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Silver Oak Securities held 20,680 shares of ALPS Medical Breakthroughs ETF worth $1.34M as of Q2 2026.
  • Silver Oak Securities bought 4,091 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $224K.
  • ALPS Medical Breakthroughs ETF made up 0.08% of Silver Oak Securities's portfolio in Q2 2026, its #231 holding.
  • Silver Oak Securities first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.